Anticytomegaloviral activity of esterified milk proteins and L-polylysines

Journal of Molecular Microbiology and Biotechnology

Volumn 13, Issue 4, 2007, Pages 255-258

  Chobert, Jean Marc ^a   Sitohy, Mahmoud ^a,c   Billaudel, Sylviane ^b   Dalgalarrondo, Michèle ^a   Haertlé, Thomas ^a  

^a INRA   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Zagazig University   (Egypt)

Author keywords

Antiviral activity; Cytomegalovirus; Esterification; Milk; Peptic peptides; Polylysines; Proteins

Indexed keywords

ALPHA LACTALBUMIN; BETA LACTOGLOBULIN; MILK PROTEIN; POLYLYSINE; PROTEIN HYDROLYSATE;

ANTIVIRAL ACTIVITY; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; ESTERIFICATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN;

ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; ESTERIFICATION; FIBROBLASTS; HUMANS; LACTALBUMIN; LACTOGLOBULINS; METHYLATION; MILK PROTEINS; POLYLYSINE;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 34548500851     PISSN: 14641801     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104755     Document Type: Conference Paper

References (28)

1. Crumpacker CS: Ganciclovir. Drug Ther 1996;335:721-729.
2. Lalezari JP, Stagg RJ, Jaffe HS, Hitchcock MJ, Drew WL: Preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC). Adv Exp Med Biol 1996;394:105-115.
3. Chrisp P, Clissold SP: Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991;41:104-129.
4. Field AK, Biron KK: 'The end of innocence' revisited: resistance of herpes viruses to antiviral drugs. Clin Microbiol Rev 1994;7:1-13.
5. Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M, Gerna G: Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J Med Virol 1995;47:237-244.
6. Harada K, Eizuru Y, Isashiki Y, Ihara S, Minamishima Y: Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Arch Virol 1997;142:215-225.
7. Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Drobyski WR, Knox KK, Carrigan DR, Ash RC: Foscarnet therapy for ganciclovir-resistant cytomegalovirus in marrow transplantation. Transplantation 1991;52:155-157.
8. Slavin MA, Bindra RR, Gleaves CA, Pettinger MB, Bowden RA: Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother 1993;37:1360-1363.
9. Wolf DG, Yaniv I, Honigman A, Kassis I, Schonfel T, Ashkenazi S: Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency. J Infect Dis 1998;178:535-538.
10. Alford CA, Britt WJ: Cytomegalovirus; in Roizman B, Whitley RJ, Lopez D (eds): The Herpes Viruses. New York, Raven Press, 1993, pp 227-255.
11. Mocarski ESJ: Cytomegalovirus biology and replication, in Roizman B, Whitley RJ, Lopez D (eds): The Herpes Viruses. New York, Raven Press, 1993, pp 173-226.
12. Kondo KH, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 1994;91:11879-11883.
13. Kondo KH, Xu J, Mocarski ES: Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996;93:11137-11142.
14. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL: Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 1996;93:11327-11333.
15. Jones TR, Sun L: Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chain. J Virol 1997;71:2970-2979.
16. Reddehase MJ: The immunogenicity of human and murine cytomegaloviruses. Curr Opin Immunol 2000;12:390-396.l
17. Tugizov S, Maidji E, Xiao J, Pereira A: An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from plasma membrane. J Virol 1999;73:8677-8688.
18. Boyle KA, Compton T: Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J Virol 1998;72:1826-1833.
19. Sitohy M, Chobert J-M, Karwowska U, Gozdzicka-Jozefiak A, Haertlé T: Inhibition of bacteriophage M13 replication with esterified milk proteins. J Agric Food Chem 2006;54:3800-3806.
20. Sitohy M, Chobert J-M, Haertlé T: Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins, and L -polylysines. J Agric Food Chem 2005;53:3727-3734.
21. Sitohy M, Chobert J-M, Gaudin J-C, Renac T, Haertlé T: When positively charged milk proteins can bind to DNA. J Food Biochem 2002;26:511-532.
22. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Iron KK: A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992;358:162-164.
23. Mailliart P, Ribadeau Dumas B: Preparation of β-lactoglobulin and β-lactoglobulin-free proteins from whey retentate by NaCl salting out at low pH. J Food Sci 1988;53:743-752.
24. Sitohy M, Chobert J-M, Haertlé T: Simplified short-time method for the esterification of milk proteins. Milchwissenschaft 2001;56:127-131.
25. Halpin MI, Richardson T: Elected functionality changes of β-lactoglobulin upon esterification of side chain carboxyl groups. J Dairy Sci 1985;68:3189-3198.
26. Bertrand-Harb C, Chobert J-M, Dufour E, Haertlé T: Esterification of food proteins: characterization of the derivatives by a colorimetric method and by electrophoresis. Sci Aliments 1991;11:641-652.
27. Sitohy M, Chobert, JM, Haertlé T: Peptic hydrolysis of methyl-, ethyl- and propyl-esters of β-casein and α-lactalbumin: Milchwissenschaft 2001;56:303-307.
28. Sitohy M, Chobert JM, Dalgalarrondo M, Haertlé T: Factors influencing pepsinolysis of methyl-, ethyl- and propyl-ester derivatives of β-lactoglobulin. J Food Biochem 2001;25:181-198.